genocea biosciences

Genocea Biosciences Inc (GNCA) Downgraded by Zacks Investment Research to Hold
www.emqtv.com

It has two product candidates in Phase II clinical development: GEN-003 and GEN-004. It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria.

9
Like
Save
FY2015 EPS Estimates for Genocea Biosciences Inc (GNCA) Decreased by Analyst
beanstockd.com

It has two product candidates in Phase II clinical development: GEN-003 and GEN-004. It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria.

5
Like
Save
Genocea Biosciences Inc (NASDAQ:GNCA) Receives Consensus Rating of "Buy" from …
www.emqtv.com

It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria. It also creates a library of every protein in the proteome of the pathogen of interest. It …

9
Like
Save
Genocea Biosciences Inc (NASDAQ:GNCA) Given Average Recommendation of "Buy" by …
www.dakotafinancialnews.com

It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria. It also creates a library of every protein in the proteome of the pathogen of interest. It …

2
Like
Save
Genocea Biosciences Inc (GNCA) Sees Strong Trading Volume
putnamstandard.com

It has two product candidates in Phase II clinical development: GEN-003 and GEN-004. It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria.

5
Like
Save
Genocea Biosciences Inc (GNCA) Stock Price Down 5%
putnamstandard.com

It has two product candidates in Phase II clinical development: GEN-003 and GEN-004. It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria.

9
Like
Save
Genocea Biosciences Inc (NASDAQ:GNCA) Given Average Rating of "Buy" by Brokerages
putnamstandard.com

It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria. It also creates a library of every protein in the proteome of the pathogen of interest. It …

6
Like
Save
Latest Analysts Reports On Genocea Biosciences Inc (GNCA)
www.risersandfallers.com

It has two product candidates in Phase II clinical development: GEN-003 and GEN-004. It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria.

8
Like
Save
Genocea Biosciences Inc (NASDAQ:GNCA) Receives Average Recommendation of "Buy …
www.wkrb13.com

It also has product candidates, which are GEN-001, GEN-002 and GEN-005 in pre-clinical development for diseases, including genital herpes, chlamydia and malaria. It also creates a library of every protein in the proteome of the pathogen of interest. It …

7
Like
Save
Equities Analysts Set Expectations for Genocea Biosciences' Q4 2015 Earnings …
www.dakotafinancialnews.com

Additionally, it has product candidates, which are GEN001, GEN-002 and GEN 005 in pre-clinical development for diseases, including chlamydia genital herpes and malaria. It also creates a library of each and every protein in the proteome of the pathogen.

7
Like
Save